Phase I randomized study of 0.15% UF-021 in patients with geographic atrophy treated after wet age-related macular degeneration

Phase I randomized study of 0.15% UF-021 in patients with geographic atrophy treated after wet age-related macular degeneration - Phase I Study of 0.15% UF-021 in patients with geographic atrophy treated after wet AMD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007881

Enrollment

Registered

2012-05-02

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-related macular degeneraiton

Interventions

0.15% UF-021 clear eye drop

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Decimal visual acuity is more than 0.1 dry macula over 6 months GA is detected with fundus examination and fundus autofluorescence

Exclusion criteria

Exclusion criteria: Photocoagulation scar around macula Glaucoma, vitreous opacity, optic neuropathy Uncontrollable diabetes, myocardiac infarction, angina, pregnancy

Design outcomes

Primary

Measure	Time frame
To prevent the expanding of geographic atrophy	—

Secondary

Measure	Time frame
To improve the retinal sensitivity	—

Countries

Japan

Contacts

Public ContactChieko Shiragami

Kagawa university faculty of medicine Dept. of Ophthalmology

chappi@kms.ac.jp+81-87-891-2211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026